Search

Home > The Rounds Table > Prostatectomy, pharmacare, and protein mutations
Podcast: The Rounds Table
Episode:

Prostatectomy, pharmacare, and protein mutations
Category: Science & Medicine
Duration: 00:00:00
Publish Date: 2014-03-19 04:28:36
Description:

Subscribe on iTunes

This week: prostatectomy, prescription drug costs, exome sequencing for rare mutations

Learning objectives – Amol, Nathan, and Travis discuss:
1. Understand that radical prostatectomy improved overall and disease free survival and decreased metastasis compared with watchful waiting in men with localized prostate cancer of intermediate grade.
2. Understand how the cost of prescription drugs is regulated in Canada and how this impacts patients
3. Understand the application of exome sequencing to genetic discovery in rare clinical syndromes

Continuing medical education

Internists can receive 0.5 hours of Continuing Medical Education credit for each podcast they listen to through the Canadian Society of Internal Medicine (MOC Category 1) and the American Medical Association (PRA Category 1). To receive CME credit for listening to this podcast, please click here to fill out our Evaluation and Impact Assessment Form.

The papers

Anna Bill-Axelson et al. Radical prostatectomy or watchful waiting in early prostate cancer. N Engl J Med. 2014; 370:932-942. (PubMed)

Karen Tang et al. Addressing cost-related barriers to prescription drug use in Canada. CMAJ. 2014 Mar 4;186(4):276-80. (PubMed)

Paulina Navon Alkon et al. Mutant Adenosine Deaminase 2 in a Polyarteritis Nodosa Vasculopathy. N Engl J Med. 2014; 370:921-931. (PubMed)

Good stuff

Nathan – In New York, a Heart Surgery Factory With ‘Obscene Levels’ of Pay, David Armstrong et al, Bloomberg, Mar 6, 2014. 

Travis – Long-Acting Integrase Inhibitor Protects Macaques from Intrarectal Simian/Human Immunodeficiency Virus, Chastity D. Andrews et al, Science, Mar 7, 2014. 

Amol – Thirty-thousand-year-old distant relative of giant icosahedral DNA viruses with a pandoravirus morphology, Matthieu Legendre et al, PNAS, Jan 30, 2014.

Corrections

The Rounds Table is a free-flowing conversation and we may mis-speak (or just plain be wrong) from time to time. We will do our best to catch mistakes and where possible, we will edit the episode to correct the error. We will indicate here if any change has been made. If you notice anything, please let us know!

In the original recording, Amol made reference to spending on drugs being 70% public and 30% private. This was an error – 70/30 is the public/private split for overall health care spending in Canada. The correct distribution of drug spending in Canada is 46.5% public, 36% private insurance, and 17.5% out-of-pocket. Reference: CIHI, Drug Expenditures in Canada 1985-2010, table 1, page 10.). The podcast has been edited to reflect the accurate numbers.

Question of the week

Should Canada have a national drug plan?

The post Prostatectomy, pharmacare, and protein mutations appeared first on Healthy Debate.
Total Play: 0